0001062993-22-024356.txt : 20221221 0001062993-22-024356.hdr.sgml : 20221221 20221221192836 ACCESSION NUMBER: 0001062993-22-024356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221219 FILED AS OF DATE: 20221221 DATE AS OF CHANGE: 20221221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heffernan Michael Thomas CENTRAL INDEX KEY: 0001448914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 221479502 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC. STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-12-19 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001448914 Heffernan Michael Thomas C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 1 0 0 0 Common Stock 2022-12-19 4 M 0 3606 16.150 A 31629 D Common Stock 2022-12-19 4 S 0 3606 23.04 D 28023 D Common Stock 2022-12-20 4 M 0 33758 16.150 A 61781 D Common Stock 2022-12-20 4 S 0 33758 23.08 D 28023 D Common Stock 2022-12-21 4 M 0 46600 16.15 A 74623 D Common Stock 2022-12-21 4 S 0 46600 23.11 D 28023 D Stock Option (Right to Purchase) 16.150 2022-12-19 4 M 0 3606 0 D 2026-01-20 Common Stock 3606 105399 D Stock Option (Right to Purchase) 16.150 2022-12-20 4 M 0 33758 0 D 2026-01-20 Common Stock 33758 71641 D Stock Option (Right to Purchase) 16.150 2022-12-21 4 M 0 46600 0 D 2026-01-20 Common Stock 46600 25041 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4). The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable. /s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan 2022-12-21